Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.
Med (N Y). 2021 Mar 12;2(3):281-295.e4. doi: 10.1016/j.medj.2021.02.001. Epub 2021 Feb 10.
Med (N Y). 2021.
PMID: 33589885
Free PMC article.